Both in Medical Labs
Caris Life Sciences vs Quest Diagnostics
Over the past year CAI returned +14.1% and DGX returned +43.1%; their daily moves had a correlation of 0.21.
CAI +14.1% DGX +43.1%Growth of $1, one year, split-adjusted
| Metric | CAI | DGX |
|---|---|---|
| Price | $34.33 | $251.82 |
| Market cap | $9.70B | $27.79B |
| Today | −5.01% | −0.43% |
| 1 month | +21.1% | +9.0% |
| 6 months | +85.9% | +30.7% |
| Year to date | +27.2% | +45.1% |
| 1 year | +16.6% | +44.1% |
| Revenue growth (YoY) | +45.4% | +10.0% |
| Gross margin | 68.1% | 33.6% |
| Net margin | −0.2% | 10.0% |
| P/E (TTM) | 92.3× | 24.7× |
| Price / sales | 9.8× | 2.3× |
| Net cash | $400.0M | -$4.75B |
| Dividend yield | — | 1.37% |
| Volatility (60d) | 67.8% | 20.8% |
| Short % of float | 12.5% | 3.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).